With one short announcement on Thursday, the oppies were suddenly in the money.
If they had let the announcement run to its potential, support the news with media coverage - and then follow it up with one more announcement, ie; Case Western AML trial, or perhaps patient 2 and 3 in the CDH-17 trial, then I'm positive that we would start to see holders converting their oppies.
Instead, their strategy is to kill the share price, fail to promote the excellent results, further dilute the register and still withhold data from the market.
There are so many things wrong with the way that this Company is being run. If this were private industry, they'd all be looking for new jobs.
CHM Price at posting:
0.8¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)